Nail toxicity is an uncommon cutaneous adverse effect of imatinib mesylate. Here, we have described a 45-year-old female, a diagnosed case of Philadelphia positive chronic myeloid leukemia, who was on imatinib mesylate for the past 3 months and developed bluish discoloration of the nails. This discoloration was related to the drug imatinib mesylate because the patient was only on imatinib and thyroxine medication. No any other skin-related diseases was present, which can lead to her nail changes.
Bluish Nail; Imatinib; Chronic Myeloid Leukemia
Dendritic spine density changes and homeostatic synaptic scaling: a meta-analysis of animal studies.
Moulin TC, RayÃªe D, SchiÃ¶th HB
Neural regeneration research. 2022; 17(1): 20-24
Effects of electroacupuncture on pain sensation in a rat model of hyperalgesia with nicotine dependence.
Wang SJ, Zhang YP, Candiotti KA
Neural regeneration research. 2022; 17(4): 905-910
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.
Mao T, Israelow B, Lucas C, Vogels CBF, Gomez-Calvo ML, Fedorova O, Breban MI, Menasche BL, Dong H, Linehan M, , Wilen CB, Landry ML, Grubaugh ND, Pyle AM, Iwasaki A
The Journal of experimental medicine. 2022; 219(1):
Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
Peterkin A, Laks J, Weinstein ZM
The Medical clinics of North America. 2022; 106(1): 61-80
Glucose transporterâ€‘1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells.
Shima T, Taniguchi K, Tokumaru Y, Inomata Y, Arima J, Lee SW, Takabe K, Yoshida K, Uchiyama K
Oncology reports. 2022; 47(1):